ONC - BeiGene, Ltd.
299.02
1.980 0.662%
Share volume: 337,602
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$297.04
1.98
0.01%
View ratios
| Fiscal Date | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 02-27-2025 | 05-07-2025 | 08-06-2025 | 11-06-2025 | 02-26-2026 | |
| Cash flow financing | -4.523 M | -33.777 M | 35.025 M | 961.272 M | 96.931 M | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | -4.044 M | |
| Cash flow | -22.968 M | -111.636 M | 232.018 M | 1.315 B | 475.943 M | |
| Net income | -151.881 M | 1.270 M | 94.320 M | 124.841 M | 66.502 M | |
| Depreciation | 50.246 M | 32.804 M | 35.614 M | 37.284 M | 35.984 M | |
| Changes in inventories | 0.000 | -3.987 M | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -93.605 M | -121.941 M | -66.605 M | -49.274 M | -38.335 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 17.881 M | -7.334 M | -2.779 M | -499.000 K | 9.375 M | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 92.480 M | 56.407 M | 43.826 M | 48.084 M | 37.522 M | |
| Cash Change | -74.681 M | -108.156 M | 255.495 M | 1.324 B | 499.105 M |